dosing when switching from semaglutide to tirzepatide Tirzepatide: A Provider's Guide transitioning from tirzepatide to semaglutide

Early research in rodents suggested a potential link between GLP-1 receptor agonists and thyroid C-cell tumours (medullary thyroid carcinoma)

Vitamin B12, also known as cobalamin, is an essential nutrient that your body needs but cannot produce on its own[1]

Originally developed for the management of type 2 diabetes, semaglutide has also shown promise in the field of weight management

Sources Capehorn MS, Catarig AM, Furberg JK, Janez A, Price HC, Tadayon S, Vergs B, Marre M

But semaglutide is not a magic solution, and the information landscape surrounding it ranges from overly optimistic to unnecessarily alarming